| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |